194 related articles for article (PubMed ID: 34551978)
1. Interprotomer disulfide-stabilized variants of the human metapneumovirus fusion glycoprotein induce high titer-neutralizing responses.
Stewart-Jones GBE; Gorman J; Ou L; Zhang B; Joyce MG; Yang L; Cheng C; Chuang GY; Foulds KE; Kong WP; Olia AS; Sastry M; Shen CH; Todd JP; Tsybovsky Y; Verardi R; Yang Y; Collins PL; Corti D; Lanzavecchia A; Scorpio DG; Mascola JR; Buchholz UJ; Kwong PD
Proc Natl Acad Sci U S A; 2021 Sep; 118(39):. PubMed ID: 34551978
[TBL] [Abstract][Full Text] [Related]
2. Structure-based design of a single-chain triple-disulfide-stabilized fusion-glycoprotein trimer that elicits high-titer neutralizing responses against human metapneumovirus.
Ou L; Chen SJ; Teng IT; Yang L; Zhang B; Zhou T; Biju A; Cheng C; Kong WP; Morano NC; Stancofski ED; Todd JP; Tsybovsky Y; Wang S; Zheng CY; Mascola JR; Shapiro L; Woodward RA; Buchholz UJ; Kwong PD
PLoS Pathog; 2023 Sep; 19(9):e1011584. PubMed ID: 37738240
[TBL] [Abstract][Full Text] [Related]
3. Structure, Immunogenicity, and Conformation-Dependent Receptor Binding of the Postfusion Human Metapneumovirus F Protein.
Huang J; Chopra P; Liu L; Nagy T; Murray J; Tripp RA; Boons GJ; Mousa JJ
J Virol; 2021 Aug; 95(18):e0059321. PubMed ID: 34160259
[TBL] [Abstract][Full Text] [Related]
4. Engineering, Structure and Immunogenicity of the Human Metapneumovirus F Protein in the Postfusion Conformation.
Más V; Rodriguez L; Olmedillas E; Cano O; Palomo C; Terrón MC; Luque D; Melero JA; McLellan JS
PLoS Pathog; 2016 Sep; 12(9):e1005859. PubMed ID: 27611367
[TBL] [Abstract][Full Text] [Related]
5. Structure-based design of prefusion-stabilized human metapneumovirus fusion proteins.
Hsieh CL; Rush SA; Palomo C; Chou CW; Pickens W; Más V; McLellan JS
Nat Commun; 2022 Mar; 13(1):1299. PubMed ID: 35288548
[TBL] [Abstract][Full Text] [Related]
6. Structure-based design of a quadrivalent fusion glycoprotein vaccine for human parainfluenza virus types 1-4.
Stewart-Jones GBE; Chuang GY; Xu K; Zhou T; Acharya P; Tsybovsky Y; Ou L; Zhang B; Fernandez-Rodriguez B; Gilardi V; Silacci-Fregni C; Beltramello M; Baxa U; Druz A; Kong WP; Thomas PV; Yang Y; Foulds KE; Todd JP; Wei H; Salazar AM; Scorpio DG; Carragher B; Potter CS; Corti D; Mascola JR; Lanzavecchia A; Kwong PD
Proc Natl Acad Sci U S A; 2018 Nov; 115(48):12265-12270. PubMed ID: 30420505
[TBL] [Abstract][Full Text] [Related]
7. Structure-Based Design of a Soluble Prefusion-Closed HIV-1 Env Trimer with Reduced CD4 Affinity and Improved Immunogenicity.
Chuang GY; Geng H; Pancera M; Xu K; Cheng C; Acharya P; Chambers M; Druz A; Tsybovsky Y; Wanninger TG; Yang Y; Doria-Rose NA; Georgiev IS; Gorman J; Joyce MG; O'Dell S; Zhou T; McDermott AB; Mascola JR; Kwong PD
J Virol; 2017 May; 91(10):. PubMed ID: 28275193
[TBL] [Abstract][Full Text] [Related]
8. Influence of Respiratory Syncytial Virus F Glycoprotein Conformation on Induction of Protective Immune Responses.
Palomo C; Mas V; Thom M; Vázquez M; Cano O; Terrón MC; Luque D; Taylor G; Melero JA
J Virol; 2016 Jun; 90(11):5485-5498. PubMed ID: 27009962
[TBL] [Abstract][Full Text] [Related]
9. A monomeric uncleaved respiratory syncytial virus F antigen retains prefusion-specific neutralizing epitopes.
Swanson KA; Balabanis K; Xie Y; Aggarwal Y; Palomo C; Mas V; Metrick C; Yang H; Shaw CA; Melero JA; Dormitzer PR; Carfi A
J Virol; 2014 Oct; 88(20):11802-10. PubMed ID: 25078705
[TBL] [Abstract][Full Text] [Related]
10. Flexible RSV Prefusogenic Fusion Glycoprotein Exposes Multiple Neutralizing Epitopes that May Collectively Contribute to Protective Immunity.
Patel N; Tian JH; Flores R; Jacobson K; Walker M; Portnoff A; Gueber-Xabier M; Massare MJ; Glenn G; Ellingsworth L; Smith G
Vaccines (Basel); 2020 Oct; 8(4):. PubMed ID: 33066540
[TBL] [Abstract][Full Text] [Related]
11. A Potent Neutralizing Site III-Specific Human Antibody Neutralizes Human Metapneumovirus
Bar-Peled Y; Diaz D; Pena-Briseno A; Murray J; Huang J; Tripp RA; Mousa JJ
J Virol; 2019 Oct; 93(19):. PubMed ID: 31292250
[TBL] [Abstract][Full Text] [Related]
12. Human metapneumovirus virus-like particles induce protective B and T cell responses in a mouse model.
Cox RG; Erickson JJ; Hastings AK; Becker JC; Johnson M; Craven RE; Tollefson SJ; Boyd KL; Williams JV
J Virol; 2014 Jun; 88(11):6368-79. PubMed ID: 24672031
[TBL] [Abstract][Full Text] [Related]
13. Lung CD8+ T Cell Impairment Occurs during Human Metapneumovirus Infection despite Virus-Like Particle Induction of Functional CD8+ T Cells.
Wen SC; Schuster JE; Gilchuk P; Boyd KL; Joyce S; Williams JV
J Virol; 2015 Sep; 89(17):8713-26. PubMed ID: 26063431
[TBL] [Abstract][Full Text] [Related]
14. Structure and immunogenicity of pre-fusion-stabilized human metapneumovirus F glycoprotein.
Battles MB; Más V; Olmedillas E; Cano O; Vázquez M; Rodríguez L; Melero JA; McLellan JS
Nat Commun; 2017 Nov; 8(1):1528. PubMed ID: 29142300
[TBL] [Abstract][Full Text] [Related]
15. A tale of two fusion proteins: understanding the metastability of human respiratory syncytial virus and metapneumovirus and implications for rational design of uncleaved prefusion-closed trimers.
Lee YZ; Han J; Zhang YN; Ward G; Gomes KB; Auclair S; Stanfield RL; He L; Wilson IA; Zhu J
bioRxiv; 2024 Mar; ():. PubMed ID: 38496645
[TBL] [Abstract][Full Text] [Related]
16. Antibody recognition of the Pneumovirus fusion protein trimer interface.
Huang J; Diaz D; Mousa JJ
PLoS Pathog; 2020 Oct; 16(10):e1008942. PubMed ID: 33035266
[TBL] [Abstract][Full Text] [Related]
17. Alternative Virus-Like Particle-Associated Prefusion F Proteins as Maternal Vaccines for Respiratory Syncytial Virus.
Blanco JCG; Fernando LR; Zhang W; Kamali A; Boukhvalova MS; McGinnes-Cullen L; Morrison TG
J Virol; 2019 Dec; 93(23):. PubMed ID: 31511382
[TBL] [Abstract][Full Text] [Related]
18. Novel Respiratory Syncytial Virus-Like Particle Vaccine Composed of the Postfusion and Prefusion Conformations of the F Glycoprotein.
Cimica V; Boigard H; Bhatia B; Fallon JT; Alimova A; Gottlieb P; Galarza JM
Clin Vaccine Immunol; 2016 Jun; 23(6):451-9. PubMed ID: 27030590
[TBL] [Abstract][Full Text] [Related]
19. Immunogenicity in mice of human metapneumovirus with a truncated SH glycoprotein.
Tedcastle AB; Fenwick F; Robinson MJ; Toms GL
J Med Virol; 2014 Apr; 86(4):547-57. PubMed ID: 24009128
[TBL] [Abstract][Full Text] [Related]
20. A Pan-Pneumovirus vaccine based on immunodominant epitopes of the fusion protein.
Huang J; Miller RJ; Mousa JJ
Front Immunol; 2022; 13():941865. PubMed ID: 36003370
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
